Dual anti-platelet therapy and dento-alveolar surgery. How do we manage patients on anti-platelet medication?

被引:0
|
作者
N. Patel
V. Patel
D. Sarkar
T. Nokes
P. Blacklock
机构
[1] Academic Clinical Fellow in Oral Surgery,Oral Surgery Department
[2] The University of Manchester,undefined
[3] School of Dentistry,undefined
[4] StR Oral Surgery,undefined
[5] Fl 23,undefined
[6] Guys Dental Hospital,undefined
[7] Guys & St Thomas NHS Foundation Trust,undefined
[8] Cons Cardiologist Derriford Hospital,undefined
[9] Plymouth,undefined
[10] PL6 8DH,undefined
[11] Consultant Haematologist Derriford Hospital,undefined
[12] Plymouth,undefined
[13] PL6 8DH,undefined
[14] Associate Specialist Oral and Maxillofacial Surgery,undefined
[15] Derriford Hospital,undefined
[16] Plymouth,undefined
[17] PL6 8DH,undefined
来源
British Dental Journal | 2014年 / 217卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Explains the uses of anti-platelet drugs.Reports variation in the practice of managing these patients.Suggests there is no high quality evidence on how to best manage patients taking dual anti-platelet medication undergoing dentoalveolar surgery.
引用
收藏
页码:E24 / E24
相关论文
共 50 条
  • [31] Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
    Jaeger, Bernhard
    Piackova, Editha
    Haller, Paul Michael
    Andric, Tijana
    Kahl, Beatrice
    Christ, Guenther
    Geppert, Alexander
    Wojta, Johann
    Huber, Kurt
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (01) : 65 - 71
  • [32] Comparison of the Glasgow-Blatchford Risk Score vs AIMS65 Score in Patients on Coumadin and Anti-platelet Therapy or Dual Anti-platelet Therapy
    Gill, Baljinder
    Soman, Sandeep
    Bhan, Amit
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S494 - S495
  • [33] Pharmacogenomics of Anti-platelet and Anti-coagulation Therapy
    Adam S. Fisch
    Christina G. Perry
    Sarah H. Stephens
    Richard B. Horenstein
    Alan R. Shuldiner
    Current Cardiology Reports, 2013, 15
  • [34] Pharmacogenomics of Anti-platelet and Anti-coagulation Therapy
    Fisch, Adam S.
    Perry, Christina G.
    Stephens, Sarah H.
    Horenstein, Richard B.
    Shuldiner, Alan R.
    CURRENT CARDIOLOGY REPORTS, 2013, 15 (07)
  • [35] FREQUENCY OF ANTI-PLATELET ANTIBODIES IN PATIENTS WITH PLATELET REFRACTORINESS
    Lee, T.
    VOX SANGUINIS, 2013, 105 : 242 - 243
  • [36] Anti-platelet drugs: Do they affect megakaryocytes?
    Cazenave, JP
    Gachet, C
    BAILLIERES CLINICAL HAEMATOLOGY, 1997, 10 (01): : 163 - 180
  • [37] Anti-platelet therapy in non-cardiac elective surgery
    Clevenger, B.
    Jaggar, S.
    BRITISH JOURNAL OF ANAESTHESIA, 2012, 108 (04) : 699 - 699
  • [38] Anti-platelet therapy and managing ulcer risk
    Chan, Francis K. L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (02) : 195 - 199
  • [39] Impact of Platelet Count on Bleeding in the Setting of Anti-Platelet Therapy
    Lee, Robert Hugh
    Bergmeier, Wolfgang
    BLOOD, 2020, 136
  • [40] Anti-platelet therapy in small animal medicine
    Thomason, J.
    Lunsford, K.
    Mackin, A.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2016, 39 (04) : 318 - 335